Evolent Health, Inc.
Evolent Health, Inc. is a U.S.-based management services company focused on specialty care management and value-based care enablement for health plans and other risk-bearing healthcare organizations. It uses technology-enabled clinical pathways and administrative services to help customers manage complex, high-cost conditions such as oncology, cardiology, musculoskeletal care, radiology, and genetics.
Fiscal year 2025 · change from previous year
Development 2020–2025
Business
Share of revenueCore services that manage complex specialty conditions and guide care decisions across oncology, cardiology, musculoskeletal, radiology, and genetics.
Back-office and operational support services delivered alongside specialty care programs for payer and provider partners.
Care management and risk-related services previously associated with Evolent Care Partners and similar arrangements.
Identifi® and related implementation, workflow, and integration services that support clinical and administrative operations.
Customers
Evolent sells primarily to health plans, delegated arrangements, and other risk-bearing entities that want to manage specialty medical spend and improve care quality. It also serves health systems, providers, and physicians that participate in value-based payment models and need clinical decision support and administrative coordination.
Buy specialty care management and administrative services to manage high-cost specialty claims and improve member outcomes.
Use Evolent's programs to align incentives, manage utilization, and reduce avoidable specialty spend.
Adopt value-based care tools and workflow support to participate in alternative payment models.
Use pathway guidance and integrated technology to support evidence-based treatment decisions.
Strategy
Evolent is repositioning its portfolio toward integrated specialty care management and away from non-core activities, including the sale of Evolent Care Partners. Management is also focused on streamlining operations, migrating acquired businesses onto a common technology platform, and improving profitability while preserving its value-based care positioning.
This is the company's main revenue source and the clearest fit with its value-based care model.
A common technology and operating model should improve scalability and service consistency.
Cost reduction and organizational simplification support sustainable earnings growth.
Geography
Evolent's business is concentrated in the United States, and management states that all revenue is recognized in the U.S. and substantially all long-lived assets are located there. The company therefore has limited geographic diversification, and its exposure is tied mainly to U.S. healthcare regulation, payer dynamics, and specialty-care cost trends.
Risks
Evolent's results are exposed to U.S. healthcare regulation, reimbursement and utilization trends, and the economics of managing specialty claims. The company also faces customer concentration, regulatory/investigative risk, and execution risk as it integrates acquisitions and manages medical claims cost volatility.
- Medical claims cost inflationImpact: HighLikelihood: High
Higher disease prevalence and higher cost per active patient can increase service costs faster than pricing.
Exposure: Performance Suite and specialty care programs
- Customer concentrationImpact: HighLikelihood: Medium
A small number of payers represent a large share of revenue, so contract changes can materially affect results.
Exposure - False Claims Act / Anti-Kickback investigationsImpact: HighLikelihood: Medium
Coding, review, and claims practices can be challenged by regulators and create legal liabilities.
Exposure: DOJ CID related to unsupported diagnosis codes
- Healthcare regulatory and political changeImpact: MediumLikelihood: High
Changes in federal and state healthcare rules can alter reimbursement, compliance costs, and service design.
Exposure: U.S. managed care and value-based care markets
- Acquisition integration and restructuring executionImpact: MediumLikelihood: Low
The business depends on consolidating acquired operations and technology without disrupting service delivery.
Exposure: Platform migration and operating model changes
Accounting
Judgemental itemsAcquired businesses create goodwill that must be tested for impairment when performance weakens.
Impact: Could create large non-cash charges if reporting unit value declines
The company must estimate claims-related costs in its specialty care programs, and changes can move margins materially.
Impact: Affects revenue-to-cost matching and operating margin
The 2023 repositioning plan included severance, professional fees, and office consolidation costs.
Impact: Creates period-to-period comparability noise in SG&A
The sale of Evolent Care Partners changes the composition of reported operations and historical comparisons.
Impact: May affect segment-like trend analysis and cost base
Similar listed companies
Publicly listed companies with a comparable business focus.
Elevance Health, Inc.
ELV · Hospital & Medical Service Plans
Elevance Health is a U.S.
Evolv Technologies Holdings, Inc.
EVLV · Computer Peripheral Equipment, NEC
Fulgent Genetics, Inc.
FLGT · Services-Medical Laboratories
Evofem Biosciences, Inc.
EVFM · Pharmaceutical Preparations
Guardant Health, Inc.
GH · Services-Medical Laboratories
Guardant Health is a precision oncology company built around blood- and tissue-based cancer tests, real-world data, and AI analytics.
Evolus, Inc.
EOLS · Pharmaceutical Preparations
Last updated: 24/09/2026